from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0497/-

LFCtreatmentdescriptionclass of inhibitor

-1.207

Amikacinug/mL Amikacintranslation

-1.673

Cap5-10ug/mL Capreomycintranslation

-1.578

Rox10-50 ug/mL Roxithromycintranslation

-0.474

SM2-5 ug/mL Streptomycintranslation

1.519

Tet5-10 ug/mL Tetracyclinetranslation

-0.034

Rif0.2-5ug/mL Rifampicintranscription

1.300

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.335

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.352

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.854

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.531

Clofazimine10-13 ug/mL Clofaziminerespiration

0.284

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.647

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.446

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.282

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.196

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.403

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.222

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.176

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.445

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.724

KCN5-20 ug/mL Potassium cyaniderespiration

0.942

NaN30.2-2 mM Sodium aziderespiration

0.223

Nigericin50 uM Nigericinrespiration

-0.980

TRC10-150 ug/mL Triclosanrespiration

-0.879

TRZ10-25 ug/mL Thioridazinerespiration

-0.489

Valinomycin0.5-10 uM Valinomycinrespiration

2.719

ZnSO42 mM ZnSO4respiration

-0.244

menadione6-10 ug/mL Menadionerespiration

0.106

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.465

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.127

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.187

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.983

NRP_1Non-replicating persistence stage 1dosRassociated

0.395

Amp0.2mg/mL AmpicillincellWall

0.447

Cephalexin20-100 ug/mL CephalexincellWall

0.669

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.175

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.123

EMB10-20 ug/mL EthambutolcellWall

0.525

Eta12-40 ug/mL EthionamidecellWall

1.056

INH0.2-0.4 ug/mL IsoniazidcellWall

0.105

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.473

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.167

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.444

BZA0.12 mg/mL BenzamidearomaticAmides

0.181

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.701

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.448

H2O24 mM hydrogen peroxideDNAdamaging

-0.311

Levo10 ug/mL LevofloxacinDNAdamaging

0.522

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.504

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.448

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.171

UVUV-irradiationDNAdamaging

0.557

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.864

Antimycin12.5-50 ug/mL Antimycin A?

0.142

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.104

PA_110-50 ug/mL Antitubercular compound PA-1?

0.032

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.651

PA8240.2-2 ug/mL PA-824?

0.021

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.292

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.562

Verapamil50 uM Verapamil?

-0.364

mercaptoethanol2 mM 2-Mercaptoethanol?

0.523

methoxatin10-20 ug/mL Methoxatin?